Ke Gong

State Key Laboratory Of Systems Medicine For Cancer
Shanghai, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Thermosensitive gel-nano system against esophageal cancer via restoring p53 activity and boosting T-cell immunity.

Thermosensitive gel-nano system against esophageal cancer via restoring p53 activity and boosting T-cell immunity.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: January 19, 2024

Nanosystem Delivers Senescence Activators and Immunomodulators to Combat Liver Cancer.

Nanosystem Delivers Senescence Activators and Immunomodulators to Combat Liver Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 02, 2023

Nano Ultrasound Contrast Agent for Synergistic Chemo-photothermal Therapy and Enhanced Immunotherapy Against Liver Cancer and Metastasis.

Nano Ultrasound Contrast Agent for Synergistic Chemo-photothermal Therapy and Enhanced Immunotherapy Against Liver Cancer and Metastasis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 08, 2023

Inhibition of atherosclerosis progression by modular micelles.

Inhibition of atherosclerosis progression by modular micelles.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: January 04, 2023

Programmed prodrug breaking the feedback regulation of P-selectin in plaque inflammation for atherosclerotic therapy.

Programmed prodrug breaking the feedback regulation of P-selectin in plaque inflammation for atherosclerotic therapy.

Journal: Biomaterials

Published: April 21, 2022

Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer.

Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer.

Journal: Journal of nanobiotechnology

Published: October 22, 2021

Functional Exosome-Mediated Delivery of Triptolide Endowed with Targeting Properties as Chemotherapy Carriers for Ovarian Carcinoma.

Functional Exosome-Mediated Delivery of Triptolide Endowed with Targeting Properties as Chemotherapy Carriers for Ovarian Carcinoma.

Journal: Journal of biomedical nanotechnology

Published: April 20, 2021

The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer.

The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer.

Journal: Journal of nanobiotechnology

Published: March 15, 2021

Nanoparticle BAF312@CaP-NP Overcomes Sphingosine-1-Phosphate Receptor-1-Mediated Chemoresistance Through Inhibiting S1PR1/P-STAT3 Axis in Ovarian Carcinoma.

Nanoparticle BAF312@CaP-NP Overcomes Sphingosine-1-Phosphate Receptor-1-Mediated Chemoresistance Through Inhibiting S1PR1/P-STAT3 Axis in Ovarian Carcinoma.

Journal: International journal of nanomedicine

Published: February 07, 2020

Incorporation of drug efflux inhibitor and chemotherapeutic agent into an inorganic/organic platform for the effective treatment of multidrug resistant breast cancer.

Incorporation of drug efflux inhibitor and chemotherapeutic agent into an inorganic/organic platform for the effective treatment of multidrug resistant breast cancer.

Journal: Journal of nanobiotechnology

Published: September 30, 2019

Showing 1-10 of 10

Last Updated: 09/26/2026